RESUMEN
AbstractWe describe 70 cases of monocled cobra (Naja kaouthia) bite admitted to Chittagong Medical College Hospital, Bangladesh. The biting snakes were identified by examining the dead snake and/or detecting N. kaouthia venom antigens in patients' serum. Bites were most common in the early morning and evening during the monsoon (May-July). Ligatures were routinely applied to the bitten limb before admission. Thirty-seven patients consulted traditional healers, most of whom made incisions around the bite site. Fifty-eight patients experienced severe neurotoxicity and most suffered swelling and pain of the bitten limb. The use of an Indian polyvalent antivenom in patients exhibiting severe neurotoxicity resulted in clinical improvement but most patients experienced moderate-to-severe adverse reactions. Antivenom did not influence local blistering and necrosis appearing in 19 patients; 12 required debridement. Edrophonium significantly improved the ability of patients to open the eyes, endurance of upward gaze, and peak expiratory flow rate suggesting that a longer-acting anticholinesterase drug (neostigmine) could be recommended for first aid. The study suggested that regionally appropriate antivenom should be raised against the venoms of the major envenoming species of Bangladesh and highlighted the need to improve the training of staff of local medical centers and to invest in the basic health infrastructure in rural communities.
Asunto(s)
Antivenenos/uso terapéutico , Elapidae/fisiología , Mordeduras de Serpientes/epidemiología , Mordeduras de Serpientes/terapia , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Animales , Antivenenos/administración & dosificación , Bangladesh/epidemiología , Niño , Preescolar , Edrofonio , Venenos Elapídicos/toxicidad , Femenino , Primeros Auxilios , Humanos , Masculino , Persona de Mediana Edad , Mordeduras de Serpientes/patología , Adulto JovenRESUMEN
The aim of this study was to identify candidate antivenoms with specific activity against the venom of the saw-scaled or carpet viper (Echis ocellatus) in northern Nigeria, where bites by this species cause great morbidity and mortality but where effective antivenoms have become scarce and unaffordable. Selected antivenoms were destined to be compared by randomised controlled clinical trials (RCTs). Standard pre-clinical neutralisation assays were carried out in rodents. We included two licensed antivenoms of established clinical efficacy and 6 candidate antivenoms. Although 6 of the tested antivenoms showed promising efficacy, all but 3 were excluded from further study because of inadequate pre-clinical efficacy or because they were unavailable or unaffordable for the anticipated RCTs. Median effective doses (ED(50)) of the remaining three candidate antivenoms suggested that the following doses might neutralise the maximum observed venom yield of 24.8 mg (dry weight) of venom milked from captive E. ocellatus: 10 ml of MicroPharm "EchiTAb G" (ET-G) antivenom; 30 ml of Instituto Clodomiro Picado "EchiTAb-Plus-ICP" (ET-Plus) antivenom; 50 ml of VacSera, Cairo "EgyVac" antivenom. A preliminary clinical dose-finding and safety study of these three antivenoms was carried out in 24 patients with incoagulable blood after E. ocellatus bites who were not severely envenomed. A 3+3 dose escalation design was employed. Initial doses of 10 ml ET-G and 30 ml ET-Plus restored blood coagulability in groups of 6 patients with early mild reactions (pruritus only) in not more than one third of them. EgyVac antivenom did not fulfil efficacy or safety criteria in 12 patients. On the basis of these results, ET-G and ET-Plus were selected for comparison in a RCT.
Asunto(s)
Antivenenos/uso terapéutico , Mordeduras de Serpientes/tratamiento farmacológico , Venenos de Víboras/toxicidad , Relación Dosis-Respuesta a Droga , Humanos , NigeriaRESUMEN
The report describes successful management of 10 women in 2nd and 3rd pregnancy trimesters with EchiTab IgG antivenom after carpet viper (Echis ocellatus) envenoming. All women survived but foetal loss in a victim with delayed presentation and a case of mild hypersensitivity reaction were recorded. Excellent outcomes can be achieved in rural and semi-nomadic populations without specialized care and immediate access and provision of effective antivenoms is paramount in curtailing snakebite maternal morbidity, mortality and foetal loss.
Asunto(s)
Antivenenos/administración & dosificación , Muerte Fetal/prevención & control , Accesibilidad a los Servicios de Salud/normas , Complicaciones Hematológicas del Embarazo/tratamiento farmacológico , Mordeduras de Serpientes/tratamiento farmacológico , Venenos de Víboras/envenenamiento , Adolescente , Adulto , Animales , Estudios de Casos y Controles , Femenino , Humanos , Recién Nacido , Embarazo , Complicaciones Hematológicas del Embarazo/mortalidad , Salud Rural , Mordeduras de Serpientes/mortalidad , Factores de Tiempo , Venenos de Víboras/antagonistas & inhibidoresRESUMEN
In a prospective study of snake bites involving 10 hospitals in Sri Lanka, 302 (35%) of 860 patients with bites by identified snakes proved to have been bitten by hump-nosed pit vipers (301 by Hypnale hypnale and 1 by H. nepa). Most victims were males aged between 11 years and 50 years who had been bitten on their feet or ankles while walking at night close to their homes. There was local swelling in 276 (91%) and local necrosis in 48 (16%). Eleven (4%) required amputation of fingers or toes and 12 (4%) received skin grafts. In 117 patients (39%) blood incoagulability was first detected between 15 min and 48 h after the bite, and in 116 of them this was present on admission to hospital. Spontaneous systemic bleeding was observed in 55 patients (18%). Acute renal failure developed in 10%, five of whom died to give an overall case fatality rate of 1.7%. Thus, bites by hump-nosed pit vipers can cause debilitating local and fatal systemic envenoming. In Sri Lanka and southwestern India where bites by these snakes are common, the only available antivenoms (raised against cobra, krait, Russell's viper and saw-scaled viper venoms) are ineffective and carry a high risk of reactions.
Asunto(s)
Lesión Renal Aguda/etiología , Antivenenos/uso terapéutico , Trastornos de la Coagulación Sanguínea/etiología , Mordeduras de Serpientes/complicaciones , Venenos de Víboras/efectos adversos , Viperidae , Adolescente , Adulto , Distribución por Edad , Anciano , Animales , Niño , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Distribución por Sexo , Mordeduras de Serpientes/epidemiología , Sri Lanka/epidemiología , Adulto JovenRESUMEN
Envenoming by the West African saw-scaled viper, Echis ocellatus resembles that of most vipers, in that it results in local blistering, necrosis and sometimes life-threatening systemic haemorrhage. While effective against systemic envenoming, current antivenoms have little or no effect against local tissue damage. The major mediators of local venom pathology are the zinc-dependant snake venom metalloproteinases (SVMPs). The high degree of structural and functional homology between SVMPs and their mammalian relatives the matrix metalloproteinases (MMPs) suggests that substrate/inhibitor interactions between these subfamilies are likely to be analogous. In this study, four recently developed MMP inhibitors (MMPIs) (Marimastat, AG-3340, CGS-270 23A and Bay-12 9566) are evaluated in addition to three metal ion chelators (EDTA, TPEN and BAPTA) for their ability to inhibit the haemorrhagic activities of the medically important E. ocellatus venom and one of its haemorrhagic SVMPs, EoVMP2. As expected, the metal ion chelators significantly inhibited the haemorrhagic activities of both whole E. ocellatus venom and EoVMP2, while the synthetic MMPIs show more variation in their efficacies. These variations suggest that individual MMPIs show specificity towards SVMPs and that their application to the neutralization of local haemorrhage may require a synthetic MMPI mixture, ensuring that a close structural component for each SVMP is represented.
Asunto(s)
Quelantes/uso terapéutico , Hemorragia/prevención & control , Metaloproteasas/antagonistas & inhibidores , Inhibidores de Proteínas Quinasas/uso terapéutico , Mordeduras de Serpientes/tratamiento farmacológico , Venenos de Víboras/antagonistas & inhibidores , Animales , Compuestos de Bifenilo , Quelantes/farmacología , Cromatografía en Gel , Cromatografía Liquida , Ácido Edético/farmacología , Ácido Edético/uso terapéutico , Ácido Egtácico/análogos & derivados , Ácido Egtácico/farmacología , Ácido Egtácico/uso terapéutico , Etilenodiaminas/farmacología , Etilenodiaminas/uso terapéutico , Estudios de Evaluación como Asunto , Hemorragia/etiología , Ácidos Hidroxámicos/farmacología , Ácidos Hidroxámicos/uso terapéutico , Metaloproteasas/toxicidad , Ratones , Estructura Molecular , Compuestos Orgánicos/farmacología , Compuestos Orgánicos/uso terapéutico , Fenilbutiratos , Inhibidores de Proteínas Quinasas/farmacología , Pirazinas/farmacología , Pirazinas/uso terapéutico , Mordeduras de Serpientes/complicaciones , Estadísticas no Paramétricas , Sulfonamidas/farmacología , Sulfonamidas/uso terapéutico , Venenos de Víboras/toxicidadRESUMEN
Envenoming by snakes results in severe systemic and local pathology. Intravenous administration of antivenom, prepared from IgG of venom immunised horses or sheep, is the only effective treatment of systemic envenoming. Conventional antivenoms, formulated as intact IgG, papain-cleaved (Fab) or pepsin-cleaved F(ab')2 fragments, are however ineffective against the local venom effects because of their inability to penetrate the blood/tissue barrier. We have embarked on a new research program to examine (i) whether the unusually small (15 kDa) antigen-binding fragment of camelid heavy chain IgG (V(H)H) can be exploited to neutralise the local effects of envenoming and (ii) whether a novel antivenom to treat both the systemic and local effects of envenoming can be formulated by combining anti-snake venom V(H)H and conventional F(ab')2. In this preliminary study, we demonstrate that camels and llamas respond to immunisation with Echis ocellatus venom with high antibody titres and broad antigen specificity. These encouraging immunological results were matched by the successful elimination of venom-induced haemorrhage by IgG from the venom-immunised camels and llamas. Unexpectedly, we report for the first time that camelid serum contains a non-IgG, highly potent inhibitor of venom-induced haemorrhage.
Asunto(s)
Antivenenos/inmunología , Fragmentos Fab de Inmunoglobulinas/farmacología , Inmunoglobulina G/farmacología , Venenos de Víboras/toxicidad , Viperidae , Animales , Antivenenos/administración & dosificación , Camélidos del Nuevo Mundo , Camelus , Hemorragia/inducido químicamente , Hemorragia/tratamiento farmacológico , Inyecciones Intravenosas , Ratones , Mordeduras de Serpientes/terapia , Venenos de Víboras/antagonistas & inhibidoresRESUMEN
Two metalloproteinases, a 24-kDa P-I EoVMP1 and a 56-kDa P-III EoVMP2, have recently been isolated from the venom of the West African saw-scaled viper Echis ocellatus. We now reveal a new 65-kDa haemorrhagic group P-III metalloproteinase which we have designated EoVMP3. The aim of this study was to determine whether these three snake venom metalloproteinases (SVMPs) affect platelets and blood coagulation. EoVMP1 had no effect on the aggregation of washed human platelets, whereas EoVMP2 inhibited collagen-induced platelet aggregation. In contrast, EoVMP3 did not inhibit the aggregation of platelets by collagen but instead activated platelets in the absence of any additional co-factors. All three SVMPs were capable of activating prothrombin to varying degrees and can therefore be described as procoagulants. EoVMP1, EoVMP2 and EoVMP3 share sequence identity with other members of the reprolysin family, but differ greatly in their effects on some of the components that control haemostasis.
Asunto(s)
Coagulación Sanguínea/efectos de los fármacos , Metaloproteasas/farmacología , Agregación Plaquetaria/efectos de los fármacos , Venenos de Víboras/enzimología , Secuencia de Aminoácidos , Animales , Fibrinógeno/antagonistas & inhibidores , Fibrinógeno/química , Datos de Secuencia Molecular , Protrombina/antagonistas & inhibidores , Protrombina/química , Venenos de Víboras/aislamiento & purificación , Viperidae/metabolismoRESUMEN
A polyspecific Pan-African antivenom has been produced from the plasma of horses immunized with a mixture of the venoms of Echis ocellatus, Bitis arietans and Naja nigricollis, the three most medically important snakes in sub-Saharan Africa. The antivenom is a whole IgG preparation, obtained by caprylic acid precipitation of non-IgG plasma proteins. The antivenom effectively neutralizes the most important toxic activities of the three venoms used in the immunization in standard assays involving preincubation of venom and antivenom before testing. This antivenom compares favourably with other antivenoms designed for use in Africa with respect to neutralization of the toxins present in the venom of E. ocellatus. Caprylic acid fractionation of horse hyperimmune plasma is a simple, convenient and cheap protocol for the manufacture of high quality whole IgG antivenoms. It constitutes a potentially valuable technology for the alleviation of the critical shortage of antivenom in Africa.
Asunto(s)
Antivenenos/inmunología , Caprilatos/química , Inmunoglobulina G/inmunología , Venenos de Serpiente/antagonistas & inhibidores , Animales , Precipitación Química , Venenos Elapídicos/antagonistas & inhibidores , Venenos Elapídicos/inmunología , Venenos Elapídicos/envenenamiento , Caballos , Ratones , Venenos de Serpiente/inmunología , Venenos de Serpiente/envenenamiento , Venenos de Víboras/antagonistas & inhibidores , Venenos de Víboras/inmunología , Venenos de Víboras/envenenamientoRESUMEN
The antigenic relationship between snake venom metalloproteinases (SVMPs) was analysed using rabbit antisera raised against the native forms of two SVMPs purified from Echis ocellatus venom. Using enzyme-linked immunosorbent assay (ELISA), western blotting and two-dimensional SDS-PAGE, our findings show that antibodies raised against EoVMP1, a non-haemorrhagic class P-I 24kDa SVMP, and EoVMP2, a haemorrhagic class P-III 56kDa SVMP, demonstrate cross-reactivities which relate to the domain hierarchy observed in class P-I to P-III/IV SVMPs. A third 65kDa P-III metalloproteinase (designated EoVMP3) was also isolated from E. ocellatus venom using hydrophobic interaction, size exclusion and anion exchange chromatography. In comparative immunoassays, EoVMP2 and EoVMP3 bound strongly to the commercial monovalent ovine Fab fragment antivenom EchiTAbtrade mark (raised against the same venom), but EoVMP1 showed no cross-reactivity. This could indicate that antivenoms may lack antibodies to potentially important venom components.
Asunto(s)
Anticuerpos/inmunología , Sueros Inmunes/inmunología , Metaloproteasas/inmunología , Venenos de Víboras/enzimología , Viperidae , Animales , Western Blotting , Cromatografía en Gel , Cromatografía por Intercambio Iónico , Reacciones Cruzadas/inmunología , Electroforesis en Gel de Poliacrilamida , Ensayo de Inmunoadsorción Enzimática , Inmunoensayo , ConejosRESUMEN
BACKGROUND: The desert horned vipers (Cerastes cerastes and C. gasperettii) are the most familiar snakes of the great deserts of North Africa and the Middle East, including the plains of Iraq. They are responsible for many human snake bites. In Western countries, they are popular among exotic-snake keepers. AIM: To investigate mechanisms of life-threatening envenoming and treatment. DESIGN: Clinical investigation. METHODS: Clinical and laboratory studies with measurement of serum venom antigen concentrations by enzyme immunoassay. RESULTS: Two men bitten while handling captive Saharan horned vipers (Cerastes cerastes) in Europe developed extensive local swelling and life-threatening systemic envenoming, characterized by coagulopathy, increased fibrinolysis, thrombocytopenia, micro-angiopathic haemolytic anaemia and acute renal failure. The clinical picture is explicable by the presence in C. cerastes venom of several thrombin-like, Factor-X-activating, platelet-aggregating, haemorrhagic and nephrotoxic components. In one case, prophylactic use of subcutaneous epinephrine may have contributed to intracranial haemorrhage. The roles in treatment of heparin (rejected) and specific antivenom (recommended) are discussed. DISCUSSION: Cerastes cerastes is capable of life-threatening envenoming in humans. Optimal treatment of envenoming is by early administration of specific antivenom, and avoidance of ineffective and potentially-dangerous ancillary methods.
Asunto(s)
Lesión Renal Aguda/etiología , Trastornos de la Coagulación Sanguínea/etiología , Mordeduras de Serpientes/complicaciones , Viperidae , Adulto , Animales , Antivenenos/uso terapéutico , Hemólisis/efectos de los fármacos , Humanos , Masculino , Persona de Mediana Edad , Mordeduras de Serpientes/tratamiento farmacológico , Venenos de Víboras/inmunologíaRESUMEN
A common problem in the development of antibody-based therapeutics is the selection, usually from a large population, of specific antibodies with the desired function. One of our research objectives is to identify antibodies capable of neutralising the most important haemorrhagic and haemostasis-disruptive proteases from viper venom. Here, we describe a modification of conventional gelatin-zymography that permits the identification of antibodies capable of neutralising gelatinolytic proteases. We demonstrate that the gelatinolytic activity of viper venom proteases is neutralised by addition of viper antivenom to the matrix of conventional gelatin-zymograms. Venom protein gelatinolytic activity was unaffected by inclusion of antibody from control, non-immunised animals or immunoglobulin-depleted serum. The application of this antibody zymogram technique for future research on snake venoms is evaluated in the context of identified limitations.
Asunto(s)
Anticuerpos/inmunología , Antivenenos/inmunología , Endopeptidasas/inmunología , Gelatina/metabolismo , Venenos de Víboras/inmunología , Animales , Ratones , Pruebas de NeutralizaciónRESUMEN
World Health Organization (WHO)-recommended preclinical in vivo and in vitro studies were carried out to compare the efficacy of Brazilian, Peruvian and Colombian antivenoms in neutralizing the venom toxins responsible for the lethal, haemorrhagic, necrotizing, coagulant and defibrinogenating effects of five medically-important Peruvian snake venoms. Overall, the Brazilian antivenom was found to be the most effective followed by the Peruvian and Colombian antivenoms. However, it was concluded that all three antivenoms would be acceptable for use in a randomised clinical trial in envenomed humans in Peru.
Asunto(s)
Antivenenos/metabolismo , Antivenenos/uso terapéutico , Venenos de Crotálidos/metabolismo , Mordeduras de Serpientes/tratamiento farmacológico , Viperidae , Animales , Coagulación Sanguínea/efectos de los fármacos , Venenos de Crotálidos/toxicidad , Evaluación Preclínica de Medicamentos , Fibrinógeno/metabolismo , Hemorragia/inducido químicamente , Dosificación Letal Mediana , Ratones , Necrosis , Pruebas de Neutralización , Plasma/metabolismo , América del Sur , Especificidad de la EspecieRESUMEN
Bites by many species of venomous snake may result in local necrosis at, or extending from, the site of the bite. The use of prophylactic antibiotics to prevent infection as a complication of local necrotic envenoming is controversial. A double-blind randomized controlled trial was carried out to assess whether antibiotic therapy is effective in this situation. Two hundred and fifty-one patients, with proven envenoming by snakes of the genus Bothrops, admitted to two hospitals in Brazil, between 1990 and 1996, were randomized to receive either oral chloramphenicol (500 mg every six hours for five days) or placebo. One hundred and twenty-two of these patients received chloramphenicol (group 1) and 129 were given placebo (group 2). There were no significant differences between the groups at the time of admission. Necrosis developed in seven (5.7%) patients in group 1 and in five (3.9%) patients in group 2 (P>0.05) while abscesses occurred in six patients (4.9%) in group 1 and in six (4.7%) patients in group 2 (P>0.05). In conclusion, the use of orally-administered chloramphenicol for victims of Bothrops snake bite with signs of local envenoming on admission, is not effective for the prevention of local infections.
Asunto(s)
Absceso/prevención & control , Antibacterianos/administración & dosificación , Bothrops , Cloranfenicol/administración & dosificación , Mordeduras de Serpientes/complicaciones , Absceso/epidemiología , Absceso/etiología , Administración Oral , Adolescente , Adulto , Animales , Brasil/epidemiología , Niño , Preescolar , Método Doble Ciego , Femenino , Humanos , Lactante , Masculino , Persona de Mediana Edad , Necrosis/prevención & control , Mordeduras de Serpientes/tratamiento farmacológico , Mordeduras de Serpientes/epidemiología , Resultado del TratamientoRESUMEN
Systemic envenoming by the saw-scaled viper, Echis ocellatus, is responsible for more deaths than any other snake in West Africa. Despite its medical importance, there have been few investigations into the toxin composition of the venom of this viper. Here we describe the isolation of E. ocellatus venom gland cDNAs encoding a protein of 514 amino acids that showed 91% sequence similarity to Ecarin, a prothrombin-activating metalloproteinase from the venom of the East African viper, E. pyramidum leakeyi, that induces severe consumption coagulopathy. Structural similarities between the E. ocellatus metalloproteinase and analogues in venoms of related vipers suggest that antibodies raised to phylogenetically conserved E. ocellatus metalloproteinase domains may have potential for cross-specific and cross-generic neutralisation of analogous venom toxins.
Asunto(s)
ADN Complementario/genética , Activación Enzimática/genética , Metaloproteasas/genética , Venenos de Víboras/genética , Viperidae/genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Clonación Molecular , Datos de Secuencia Molecular , Protrombina/metabolismo , Alineación de Secuencia , Homología de SecuenciaRESUMEN
Bites by the Indian cobra (Naja naja naja) are common in India and Sri Lanka because of its close association with humans. Cobra venoms are complex and contain several toxic components, including neurotoxins that cause post-synaptic neuromuscular blockade with respiratory paralysis and even death. Bites may also cause extensive local necrosis by mechanisms not fully elucidated. Although no significant coagulopathy has been reported, N.n. naja venom can form blood clots in vitro by activating prothrombin as demonstrated by thrombin-specific chromogenic substrate. Scanning electron microscopy demonstrates that the clots formed by venom lack the thin fibrin strands of normal blood clots formed by thromboplastin or glass contact. Rheometry shows that clots formed by venom have abnormally low elasticity over an extended period and then, as the platelets contract, a retarded and more feeble increase in elasticity. Purified N.n. naja venom PLA2 inhibits platelet aggregation in PRP and explains the decreased clot retraction and retarded and compromised elasticity build up. The present study shows that the PLA2 and the prothrombin activator from N.n. naja venom have effects on haemostasis and blood clotting, although such effects are not observed systemically in envenomed humans.
Asunto(s)
Coagulación Sanguínea/efectos de los fármacos , Venenos Elapídicos/farmacología , Fármacos Hematológicos/farmacología , Trombina/efectos de los fármacos , Animales , Anticoagulantes/química , Anticoagulantes/farmacología , Coagulantes/química , Coagulantes/farmacología , Venenos Elapídicos/química , Endotelio/citología , Endotelio/efectos de los fármacos , Fármacos Hematológicos/química , Humanos , Técnicas In Vitro , Fosfolipasas A/aislamiento & purificación , Fosfolipasas A/farmacología , Fosfolipasas A2 , Agregación Plaquetaria/efectos de los fármacos , Inhibidores de Agregación Plaquetaria/química , Inhibidores de Agregación Plaquetaria/farmacología , Protrombina/efectos de los fármacos , Trombina/química , Trombina/ultraestructura , Trombosis/inducido químicamente , Venas Umbilicales/citologíaRESUMEN
Envenoming by Echis saw scaled vipers and Bitis arietans puff adders is the leading cause of death and morbidity in Africa due to snake bite. Despite their medical importance, the composition and constituent functionality of venoms from these vipers remains poorly understood. Here, we report the cloning of cDNA sequences encoding seven clusters or isoforms of the haemostasis-disruptive C-type lectin (CTL) proteins from the venom glands of Echis ocellatus, E. pyramidum leakeyi, E. carinatus sochureki and B. arietans. All these CTL sequences encoded the cysteine scaffold that defines the carbohydrate-recognition domain of mammalian CTLs. All but one of the Echis and Bitis CTL sequences showed greater sequence similarity to the beta than alpha CTL subunits in venoms of related Asian and American vipers. Four of the new CTL clusters showed marked inter-cluster sequence conservation across all four viper species which were significantly different from that of previously published viper CTLs. The other three Echis and Bitis CTL clusters showed varying degrees of sequence similarity to published viper venom CTLs. Because viper venom CTLs exhibit a high degree of sequence similarity and yet exert profoundly different effects on the mammalian haemostatic system, no attempt was made to assign functionality to the new Echis and Bitis CTLs on the basis of sequence alone. The extraordinary level of inter-specific and inter-generic sequence conservation exhibited by the Echis and Bitis CTLs leads us to speculate that antibodies to representative molecules should neutralise the biological function of this important group of venom toxins in vipers that are distributed throughout Africa, the Middle East and the Indian subcontinent.
Asunto(s)
Lectinas Tipo C/genética , Filogenia , Venenos de Víboras/genética , Viperidae/genética , Secuencia de Aminoácidos , Animales , Secuencia Conservada/genética , ADN Complementario/química , ADN Complementario/genética , ADN Complementario/aislamiento & purificación , Geografía , Ghana , Kenia , Lectinas Tipo C/inmunología , Datos de Secuencia Molecular , Nigeria , Pakistán , Arabia Saudita , Alineación de Secuencia , Análisis de Secuencia de ADN , Homología de Secuencia de Aminoácido , Especificidad de la Especie , Venenos de Víboras/inmunología , Viperidae/clasificación , Viperidae/inmunologíaRESUMEN
Separation of previously uncharacterised Echis ocellatus venom by phenyl-Superose FPLC (Fast Liquid Protein Chromatography) yielded eight protein fractions. Three of these displayed high proteolytic activity when assayed by in vivo and in vitro assays (including enzyme linked immunosorbant assay), and were further separated using Superdex 75 and Mono-Q FPLC. This resulted in the purification of a non-haemorrhagic 24 kDa metalloproteinase (EoVMP1, pI 7.0), and a haemorrhagic 56 kDa metalloproteinase (EoVMP2, pI 5.5). Following tryptic digest, short amino acid sequences of EoVMP1 and EoVMP2 were obtained using Edman degradation. Both sequences displayed homology when aligned with existing snake venom metalloproteinases (SVMPs). The strong homology observed among previously well-characterised SVMPs suggests that principles governing the interaction of substrates and inhibitors are likely to be similar for EoVMP1, EoVMP2 and all members of the reprolysin family.
Asunto(s)
Metaloendopeptidasas/aislamiento & purificación , Venenos de Víboras/química , Viperidae , Secuencia de Aminoácidos , Animales , Cromatografía Liquida , Colágeno Tipo IV/efectos de los fármacos , Colágeno Tipo IV/metabolismo , Ensayo de Inmunoadsorción Enzimática , Hemorragia/inducido químicamente , Hemorragia/patología , Masculino , Metaloendopeptidasas/farmacología , Ratones , Ratones Endogámicos , Datos de Secuencia Molecular , Alineación de SecuenciaRESUMEN
Currently there is a crisis in the supply of antivenom for treatment of snake bite in sub-Saharan Africa. Commercial pressures have resulted in the reduction or even cessation of production of antivenom by European manufacturers while continued production of antivenom in Africa has been threatened by the privatisation of the only remaining company based in Africa. As a consequence, there has been an increase in snake bite morbidity and mortality in many African countries. Two Latin American antivenom manufacturers have agreed to produce antivenom suitable for Africa, using venoms from the species which are of the greatest medical importance in sub-Saharan Africa. Preclinical in vivo assays of neutralising potency demonstrated that a new Pan African antivenom produced in Colombia compared favourably with the existing commercial monospecific and polyspecific antivenoms. This new antivenom, and a similar product being manufactured in Costa Rica, are now candidates for clinical testing at an appropriate site in Africa.
Asunto(s)
Antivenenos , Industria Farmacéutica/economía , Urgencias Médicas , Mordeduras de Serpientes , África del Sur del Sahara , Animales , Antivenenos/biosíntesis , Antivenenos/economía , Antivenenos/inmunología , Antivenenos/farmacología , Evaluación Preclínica de Medicamentos , Electroforesis en Gel de Poliacrilamida , Servicios Médicos de Urgencia , Caballos/inmunología , Dosificación Letal Mediana , Pruebas de Neutralización , Mordeduras de Serpientes/terapia , Venenos de Serpiente/química , Venenos de Serpiente/inmunología , Especificidad de la Especie , Organización Mundial de la SaludRESUMEN
Venom toxin-specific antibodies offer a more rational treatment of snake envenoming than conventional antivenom. Here, we describe novel cDNAs encoding phospholipase A(2) (PLA(2)) isoforms from venom gland RNA of Echis pyramidum leakeyi (Epl), Echis sochureki (Es) and Echis ocellatus (Eo). The deduced amino acid sequences of these cDNAs encoded proteins with high overall sequence identity to the viper group II PLA(2) protein family, including the 14 cysteine residues capable of forming seven disulphide bonds that characterize this group of PLA(2) enzymes. Comparison of the PLA(2) sequences from Echis with those from related vipers failed to make significant geographic, taxonomic or PLA(2)-function distinctions between these Echis PLA(2) isoforms. However, their deduced hydrophilicity profiles revealed a conserved tertiary structure that we will exploit, by epidermal DNA immunization, to generate PLA(2)-neutralizing antibodies with polyspecific potential.